Last updated: 19 May 2023 at 5:50pm EST

Gerard Brophy Net Worth




The estimated Net Worth of Gerard Brophy is at least $12 Milione dollars as of 3 March 2023. Gerard Brophy owns over 3,914 units of Avantor stock worth over $2,925,521 and over the last 5 years he sold AVTR stock worth over $5,564,457. In addition, he makes $3,521,220 as Executive Vice President - Biopharma Production at Avantor.

Gerard Brophy AVTR stock SEC Form 4 insiders trading

Gerard has made over 15 trades of the Avantor stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,914 units of AVTR stock worth $97,850 on 3 March 2023.

The largest trade he's ever made was exercising 378,580 units of Avantor stock on 11 January 2021 worth over $8,783,056. On average, Gerard trades about 27,405 units every 39 days since 2020. As of 3 March 2023 he still owns at least 108,715 units of Avantor stock.

You can see the complete history of Gerard Brophy stock trades at the bottom of the page.





Gerard Brophy biography

Dr. Gerard Brophy serves as Executive Vice President - Biopharma Production of the Company. Dr. Gerard Brophy is our Executive Vice President, Biopharma Production, a position he has held since July 2018. Dr. Brophy joined us from GE Healthcare, a medical technology and life sciences company where he spent more than 14 years in a variety of senior level positions, most recently as the Head of Cell Therapy, Life Sciences from January 2017 to July 2018, and Chief Technology Officer, Life Sciences from April 2013 to January 2017.

What is the salary of Gerard Brophy?

As the Executive Vice President - Biopharma Production of Avantor, the total compensation of Gerard Brophy at Avantor is $3,521,220. There are 3 executives at Avantor getting paid more, with Michael Stubblefield having the highest compensation of $16,995,300.



How old is Gerard Brophy?

Gerard Brophy is 54, he's been the Executive Vice President - Biopharma Production of Avantor since 2018. There are 10 older and 17 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.

What's Gerard Brophy's mailing address?

Gerard's mailing address filed with the SEC is RADNOR CORPORATE CENTER, BUILDING ONE,, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087.

Insiders trading at Avantor

Over the last 5 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri e Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.



What does Avantor do?

based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com



What does Avantor's logo look like?

Avantor Inc. logo

Complete history of Gerard Brophy stock trades at Avantor

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
3 Mar 2023 Gerard Brophy
EVP e Biopharma Production
Vendita 3,914 $25.00 $97,850
3 Mar 2023
108,715
27 Feb 2023 Gerard Brophy
EVP e Biopharma Production
Vendita 3,059 $25.00 $76,475
27 Feb 2023
112,629
31 Jan 2023 Gerard Brophy
EVP e Biopharma Production
Vendita 11,339 $25.06 $284,155
31 Jan 2023
102,385
20 May 2022 Gerard Brophy
EVP e Biopharma Production
Vendita 19,603 $31.27 $612,986
20 May 2022
96,935
1 Mar 2022 Gerard Brophy
EVP e Biopharma Production
Vendita 2,027 $34.47 $69,871
1 Mar 2022
136,221
23 Feb 2022 Gerard Brophy
EVP e Biopharma Production
Vendita 3,059 $33.79 $103,364
23 Feb 2022
125,181
2 Jan 2022 Gerard Brophy
EVP e Biopharma Production
Vendita 70,969 $40.42 $2,868,567
2 Jan 2022
131,312
30 Jul 2021 Gerard Brophy
EVP e Biopharma Production
Opzione 81,125 $23.20 $1,882,100
30 Jul 2021
230,504
20 May 2021 Gerard Brophy
EVP e Biopharma Production
Vendita 19,603 $31.10 $609,653
20 May 2021
149,379
24 Feb 2021 Gerard Brophy
EVP e Biopharma Production
Vendita 3,059 $27.93 $85,438
24 Feb 2021
172,384
22 Feb 2021 Gerard Brophy
EVP e Biopharma Production
Opzione 19,769 $17.67 $349,318
22 Feb 2021
195,212
11 Jan 2021 Gerard Brophy
EVP e Biopharma Production
Opzione 378,580 $23.20 $8,783,056
11 Jan 2021
340,763
6 Jan 2021 Gerard Brophy
EVP e Biopharma Production
Vendita 11,509 $27.24 $313,505
6 Jan 2021
178,515
2 Jan 2021 Gerard Brophy
EVP e Biopharma Production
Opzione 59,418 $18.45 $1,096,262
2 Jan 2021
249,442
20 May 2020 Gerard Brophy
EVP e Biopharma Production
Vendita 25,495 $17.36 $442,593
20 May 2020
196,583


Avantor executives and stock owners

Avantor executives and other stock owners filed with the SEC include: